IntrinsicIntrinsic

Dividends & Buybacks ·

CDT Equity Inc. announced a 1-for-10 reverse stock split to ensure continued compliance with the Nasdaq bid-price rule

CDTTWCDT Equity Inc.

CDT Equity Inc. announced a 1-for-10 reverse stock split to ensure continued compliance with the Nasdaq bid-price rule. The split becomes effective on July 17, 2026, and the company's common stock is expected to begin trading on a reverse stock split-adjusted basis on July 20, 2026. CDT Equity Inc. is a data-driven biopharmaceutical development company focused on therapeutic asset advancement through scientific innovation and strategic partnerships.

More from CDT Equity Inc.

Explore CDTTW